Cognitive Lifetime Drinking History in Nonalcoholic Fatty Liver Disease: Some Cases May Be Alcohol Related
Paul Hideyo Hayashi, Stephen A. Harrison, Sigurd Torgerson et al. · The American Journal of Gastroenterology · 2004
OBJECTIVES We aimed to determine the prevalence of significant alcohol intake in previously diagnosed nonalcoholic fatty liver (NAFL) patients. METHODS We measured current and total lifetime alcohol intake (TLAI) in biopsy-proven NAFL patients using the cognitive lifetime drinking history (CLDH), a computerized questionnaire. One nurse administered the CLDH without physician presence. Physicians took alcohol histories prior to any knowledge of this study. Advanced and nonadvanced fibrosis patients were tested. A single pathologist (ST) scored all biopsies (inflammation 0–6; fibrosis 0–4). RESULTS Twenty-three patients (11 men) were studied. Thirteen had bridging fibrosis or cirrhosis. [mean age: 52.3 yr (range 28–69); mean body mass index (BMI): 37 kg/m2 (range 27–48.6)]. All but three had hyperlipidemia, diabetes, and/or hypertension. Mean TLAI was 60.2 kg (range 0.17–471.7), but three patients were above 100 kg (threshold for cirrhosis risk) at 305.5, 336.7, and 471.7. These three had inflammation/fibrosis scores of 3/3, 3/0, and 5/2, respectively. Those with >100 kg tended to have higher serum AST and inflammation score. Prior physician-obtained alcohol history determined ≤20 g/day for all patients and did not mention TLAI in any. CLDH confirmed ≤20 g/day current alcohol intake in 21 of 23 patients, but intakes were 30.2 g/day and 41.2 g/day in two. CONCLUSIONS Some NAFL patients may have alcohol fatty liver disease instead. Routine physician interviews obtain less accurate alcohol histories compared to CLDH. The clinical significance of past alcohol intake and methods of measuring alcohol ingestion in fatty liver patients deserves further investigation.
Cited by 58 works. doi:10.1046/j.1572-0241.2003.04013.x
Authors
References
- Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
- The Continuing Epidemic of Obesity in the United States
- Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
- Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
- Reliability of alcohol use indices. The Lifetime Drinking History and the MAST.
- Burden of liver disease in the United States: Summary of a workshop
- Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
- Drinking habits as cofactors of risk for alcohol induced liver damage
- Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
- Nonalcoholic steatohepatitis